Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Anti-Snoring Devices and Snoring Surgery Market by Product Type (Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps Tongue-Stabilizing Devices (TSDs), Tongue-Stabilizing Devices (TSDs), EPAP Therapy Devices) and by Type (Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), Radiofrequency Ablation (Somnoplasty), Pillar Procedure, Injection Snoreplasty/Sclerotherapy, Other Anti-Snoring Surgical Procedures, Palatal Stiffening Procedures): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00738

Pages: NA

Charts: NA

Tables: NA

The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments have become the central point of attention for clinical reasons.

Rising awareness across developed nations related to the ill effects of snoring and huge benefits of treatments coupled with rising count of geriatric and obese population are the factors that are expected to boost the market growth. Growing cigarette consumption and alcohol intake along with technological developments in designing in anti-snoring devices are also likely to foster the market growth. Lack of efficacy and scientific validation of the anti-snoring devices along with high cost of oral appliances for customized usage are the factors that may restrain the growth of this market. The demand of antisnoring treatments across developing countries is expected to create growth opportunities in this market.

The report segments the anti-snoring treatments market on the basis of types, surgical procedures and region. On the basis of type, the market is segmented into oral appliances/mouthpieces, nasal devices, position control devices, chin straps, and tongue-stabilizing devices (TSDs) and EPAP therapy devices. The Oral Appliances/Mouthpieces is segmented into mandibular advancement devices (MADS) and tongue-retaining devices (TRDS) whereas Nasal Devices is segmented into External Nasal Dilators (or Nasal Strips) and others. On the basis of surgical procedures market, the market is segmented into Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), radiofrequency ablation (somnoplasty), pillar procedure, injection snoreplasty/sclerotherapy, palatal stiffening procedures and other anti-snoring surgical procedures. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

Key players operating in this market are Sleeping Well, LLC, Apnea Sciences Corporation, The Pure Sleep Company, Somnomed Limited, Airway Management Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline, PLC., and Meditas Ltd.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market across the globe.
  • The report offers latest technological innovations and the recent R&D developments.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations which assists in identifying the prevailing market opportunities.
  • The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding of the market.
  • Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.
  • The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
  • The report offers information on the status of new projects along with offering investment feasibility analysis of the same.

 Key Market Segments

  • By Product Type
    • Oral Appliances/Mouthpieces
      • Mandibular Advancement Devices (MADS)
      • Tongue-Retaining Devices (TRDS)
    • Nasal Devices
      • External Nasal Dilators (Nasal Strips)
      • Other Nasal Devices
    • Position Control Devices
    • Chin Straps Tongue-Stabilizing Devices (TSDs)
    • Tongue-Stabilizing Devices (TSDs)
    • EPAP Therapy Devices
  • By Type
    • Uvulopalatopharyngoplasty (UPPP)
    • Laser-Assisted Uvulopalatoplasty (LAUP)
    • Radiofrequency Ablation (Somnoplasty)
    • Pillar Procedure
    • Injection Snoreplasty/Sclerotherapy
    • Other Anti-Snoring Surgical Procedures
    • Palatal Stiffening Procedures
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA

 
Key Market Players

  • Apnea Sciences Corporation
  • Airway Management Inc.
  • Glaxosmithkline, PLC.
  • Meditas Ltd
  • Sleeping Well, LLC,
  • Theravent, Inc.
  • Tomed Dr.
  • Toussaint Gmbh
  • Somnomed Limited
  • The Pure Sleep Company

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Oral Appliances/Mouthpieces

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Mandibular Advancement Devices (MADS)

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Tongue-Retaining Devices (TRDS)

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Nasal Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. External Nasal Dilators (Nasal Strips)

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Other Nasal Devices

        • 4.3.4.1. Market Size and Forecast

    • 4.4. Position Control Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Chin Straps Tongue-Stabilizing Devices (TSDs)

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Tongue-Stabilizing Devices (TSDs)

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. EPAP Therapy Devices

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

  • CHAPTER 5: ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Type

    • 5.2. Uvulopalatopharyngoplasty (UPPP)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Laser-Assisted Uvulopalatoplasty (LAUP)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Radiofrequency Ablation (Somnoplasty)

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Pillar Procedure

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Injection Snoreplasty/Sclerotherapy

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Other Anti-Snoring Surgical Procedures

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Palatal Stiffening Procedures

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By Type

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Anti-snoring Devices And Snoring Surgery Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By Type

      • 6.2.6. Canada Anti-snoring Devices And Snoring Surgery Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By Type

      • 6.2.7. Mexico Anti-snoring Devices And Snoring Surgery Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By Type

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By Type

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Anti-snoring Devices And Snoring Surgery Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By Type

      • 6.3.6. Germany Anti-snoring Devices And Snoring Surgery Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By Type

      • 6.3.7. Italy Anti-snoring Devices And Snoring Surgery Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By Type

      • 6.3.8. Spain Anti-snoring Devices And Snoring Surgery Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By Type

      • 6.3.9. UK Anti-snoring Devices And Snoring Surgery Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By Type

      • 6.3.10. Russia Anti-snoring Devices And Snoring Surgery Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By Type

      • 6.3.11. Rest Of Europe Anti-snoring Devices And Snoring Surgery Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By Type

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By Type

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Anti-snoring Devices And Snoring Surgery Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By Type

      • 6.4.6. Japan Anti-snoring Devices And Snoring Surgery Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By Type

      • 6.4.7. India Anti-snoring Devices And Snoring Surgery Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By Type

      • 6.4.8. South Korea Anti-snoring Devices And Snoring Surgery Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By Type

      • 6.4.9. Australia Anti-snoring Devices And Snoring Surgery Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By Type

      • 6.4.10. Thailand Anti-snoring Devices And Snoring Surgery Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By Type

      • 6.4.11. Malaysia Anti-snoring Devices And Snoring Surgery Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By Type

      • 6.4.12. Indonesia Anti-snoring Devices And Snoring Surgery Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By Type

      • 6.4.13. Rest of Asia Pacific Anti-snoring Devices And Snoring Surgery Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By Type

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By Type

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Anti-snoring Devices And Snoring Surgery Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By Type

      • 6.5.6. South Africa Anti-snoring Devices And Snoring Surgery Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By Type

      • 6.5.7. Saudi Arabia Anti-snoring Devices And Snoring Surgery Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By Type

      • 6.5.8. UAE Anti-snoring Devices And Snoring Surgery Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By Type

      • 6.5.9. Argentina Anti-snoring Devices And Snoring Surgery Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By Type

      • 6.5.10. Rest of LAMEA Anti-snoring Devices And Snoring Surgery Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By Type

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Sleeping Well, LLC,

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Apnea Sciences Corporation

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. The Pure Sleep Company

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Somnomed Limited

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Airway Management Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Theravent, Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Tomed Dr.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Toussaint Gmbh

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Glaxosmithkline, PLC.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Meditas Ltd

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR ORAL APPLIANCES/MOUTHPIECES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR NASAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR POSITION CONTROL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR CHIN STRAPS TONGUE-STABILIZING DEVICES (TSDS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR TONGUE-STABILIZING DEVICES (TSDS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR EPAP THERAPY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR UVULOPALATOPHARYNGOPLASTY (UPPP), BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR LASER-ASSISTED UVULOPALATOPLASTY (LAUP), BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR RADIOFREQUENCY ABLATION (SOMNOPLASTY), BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR PILLAR PROCEDURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR INJECTION SNOREPLASTY/SCLEROTHERAPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR OTHER ANTI-SNORING SURGICAL PROCEDURES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR PALATAL STIFFENING PROCEDURES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. ITALY ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. ITALY ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. SPAIN ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. SPAIN ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. UK ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. UK ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 39. RUSSIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. RUSSIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. REST OF EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 42. REST OF EUROPE ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 44. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. CHINA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. CHINA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. JAPAN ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. JAPAN ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. INDIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. INDIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. SOUTH KOREA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. SOUTH KOREA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. AUSTRALIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. AUSTRALIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. THAILAND ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. THAILAND ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 58. MALAYSIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. MALAYSIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. INDONESIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. INDONESIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. REST OF ASIA PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. REST OF ASIA PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA ANTI-SNORING DEVICES AND SNORING SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 65. LAMEA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. LAMEA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. BRAZIL ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. BRAZIL ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH AFRICA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH AFRICA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. SAUDI ARABIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. SAUDI ARABIA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 73. UAE ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 74. UAE ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 75. ARGENTINA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 76. ARGENTINA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. REST OF LAMEA ANTI-SNORING DEVICES AND SNORING SURGERY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 78. REST OF LAMEA ANTI-SNORING DEVICES AND SNORING SURGERY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 79. SLEEPING WELL, LLC,: KEY EXECUTIVES
  • TABLE 80. SLEEPING WELL, LLC,: COMPANY SNAPSHOT
  • TABLE 81. SLEEPING WELL, LLC,: OPERATING SEGMENTS
  • TABLE 82. SLEEPING WELL, LLC,: PRODUCT PORTFOLIO
  • TABLE 83. SLEEPING WELL, LLC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. APNEA SCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 85. APNEA SCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 86. APNEA SCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 87. APNEA SCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 88. APNEA SCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. THE PURE SLEEP COMPANY: KEY EXECUTIVES
  • TABLE 90. THE PURE SLEEP COMPANY: COMPANY SNAPSHOT
  • TABLE 91. THE PURE SLEEP COMPANY: OPERATING SEGMENTS
  • TABLE 92. THE PURE SLEEP COMPANY: PRODUCT PORTFOLIO
  • TABLE 93. THE PURE SLEEP COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. SOMNOMED LIMITED: KEY EXECUTIVES
  • TABLE 95. SOMNOMED LIMITED: COMPANY SNAPSHOT
  • TABLE 96. SOMNOMED LIMITED: OPERATING SEGMENTS
  • TABLE 97. SOMNOMED LIMITED: PRODUCT PORTFOLIO
  • TABLE 98. SOMNOMED LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. AIRWAY MANAGEMENT INC.: KEY EXECUTIVES
  • TABLE 100. AIRWAY MANAGEMENT INC.: COMPANY SNAPSHOT
  • TABLE 101. AIRWAY MANAGEMENT INC.: OPERATING SEGMENTS
  • TABLE 102. AIRWAY MANAGEMENT INC.: PRODUCT PORTFOLIO
  • TABLE 103. AIRWAY MANAGEMENT INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. THERAVENT, INC.: KEY EXECUTIVES
  • TABLE 105. THERAVENT, INC.: COMPANY SNAPSHOT
  • TABLE 106. THERAVENT, INC.: OPERATING SEGMENTS
  • TABLE 107. THERAVENT, INC.: PRODUCT PORTFOLIO
  • TABLE 108. THERAVENT, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. TOMED DR.: KEY EXECUTIVES
  • TABLE 110. TOMED DR.: COMPANY SNAPSHOT
  • TABLE 111. TOMED DR.: OPERATING SEGMENTS
  • TABLE 112. TOMED DR.: PRODUCT PORTFOLIO
  • TABLE 113. TOMED DR.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. TOUSSAINT GMBH: KEY EXECUTIVES
  • TABLE 115. TOUSSAINT GMBH: COMPANY SNAPSHOT
  • TABLE 116. TOUSSAINT GMBH: OPERATING SEGMENTS
  • TABLE 117. TOUSSAINT GMBH: PRODUCT PORTFOLIO
  • TABLE 118. TOUSSAINT GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. GLAXOSMITHKLINE, PLC.: KEY EXECUTIVES
  • TABLE 120. GLAXOSMITHKLINE, PLC.: COMPANY SNAPSHOT
  • TABLE 121. GLAXOSMITHKLINE, PLC.: OPERATING SEGMENTS
  • TABLE 122. GLAXOSMITHKLINE, PLC.: PRODUCT PORTFOLIO
  • TABLE 123. GLAXOSMITHKLINE, PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. MEDITAS LTD: KEY EXECUTIVES
  • TABLE 125. MEDITAS LTD: COMPANY SNAPSHOT
  • TABLE 126. MEDITAS LTD: OPERATING SEGMENTS
  • TABLE 127. MEDITAS LTD: PRODUCT PORTFOLIO
  • TABLE 128. MEDITAS LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ANTI-SNORING DEVICES AND SNORING SURGERY MARKET
  • FIGURE 3. SEGMENTATION ANTI-SNORING DEVICES AND SNORING SURGERY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ANTI-SNORING DEVICES AND SNORING SURGERY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANTI-SNORING DEVICES AND SNORING SURGERY MARKET
  • FIGURE 11. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR ORAL APPLIANCES/MOUTHPIECES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR NASAL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR POSITION CONTROL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR CHIN STRAPS TONGUE-STABILIZING DEVICES (TSDS), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR TONGUE-STABILIZING DEVICES (TSDS), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR EPAP THERAPY DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 19. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR UVULOPALATOPHARYNGOPLASTY (UPPP), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR LASER-ASSISTED UVULOPALATOPLASTY (LAUP), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR RADIOFREQUENCY ABLATION (SOMNOPLASTY), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR PILLAR PROCEDURE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR INJECTION SNOREPLASTY/SCLEROTHERAPY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR OTHER ANTI-SNORING SURGICAL PROCEDURES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET FOR PALATAL STIFFENING PROCEDURES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: ANTI-SNORING DEVICES AND SNORING SURGERY MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. SLEEPING WELL, LLC,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. SLEEPING WELL, LLC,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. SLEEPING WELL, LLC,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. APNEA SCIENCES CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. APNEA SCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. APNEA SCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. THE PURE SLEEP COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. THE PURE SLEEP COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. THE PURE SLEEP COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. SOMNOMED LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. SOMNOMED LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. SOMNOMED LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. AIRWAY MANAGEMENT INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. AIRWAY MANAGEMENT INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. AIRWAY MANAGEMENT INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. THERAVENT, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. THERAVENT, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. THERAVENT, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. TOMED DR.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. TOMED DR.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. TOMED DR.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. TOUSSAINT GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. TOUSSAINT GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. TOUSSAINT GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. GLAXOSMITHKLINE, PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. GLAXOSMITHKLINE, PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. GLAXOSMITHKLINE, PLC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. MEDITAS LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. MEDITAS LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. MEDITAS LTD: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Anti-Snoring Devices and Snoring Surgery Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved